Novel Cu(II)-quinoline carboxamide complexes: Structural characterization, cytotoxicity and reactivity towards 5′-GMP

Junyong Zhang,Xiaokang Ke,Chao Tu,Jun Lin,Jian Ding,Liping Lin,Hoong-Kun Fun,Xiaozeng You,Zijian Guo
DOI: https://doi.org/10.1023/A:1022577420708
2003-01-01
Abstract:Three new ligands, N-(8-quinolyl)pyridine-2-carboxamide (HL 1 ), N-(8-quinolyl)glycine-N′-Boc-carboxamide (HL 2 ), N-(8-quinolyl)-L-alanine-N′-Boc-carboxamide (HL 3 ), and their Cu(II) complexes have been synthesized. Crystallographic data reveal that complex I, [Cu(L 1 )(Ac)(H 2 O)], is penta-coordinated with a square-pyramidal geometry while complexes V [Cu(L 2 ′)(H 2 O)] and VI [Cu(L 3 ′)(H 2 O)] are tetra-coordinated to give square planar geometry. In vitro tests showed that the Cu(II) complexes with L 1 (I-IV) exhibited cytotoxicity at a concentration of 10 −8 M against murine leukemia P-388 and human leukemia HL-60 cell lines, which is more potent than cisplatin. However, ligands HL 2 and HL 3 and their corresponding copper complexes demonstrated very weak in vitro activities towards the cell lines examined. ESMS data shows that complex I binds rapidly with 5′-GMP to form 1:1 and 2:2 adduct.
What problem does this paper attempt to address?